ClearPoint Neuro Inc.
CLPT | NASDAQ
$13.97
+$0.14 (+1.01%)
At close: Sep 21, 2026, 4:00 PM ET
$14
+$0.03 (+0.21%)
Pre-market:
Sep 22, 2026, 7:50 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 36.97M | 31.39M | 23.96M | 20.55M | 16.3M | 12.83M |
Cost of Revenue | 14.28M | 12.27M | 10.34M | 7.02M | 5.18M | 3.71M |
Gross Profit | 22.69M | 19.12M | 13.61M | 13.53M | 11.12M | 9.12M |
Operating Income | -24.16M | -19.75M | -22.45M | -16.33M | -13.37M | -6.22M |
Interest Income | 1.21M | 872K | 386K | n/a | n/a | n/a |
Pretax Income | -25.49M | -18.91M | -22.09M | -16.44M | -14.41M | -6.78M |
Net Income | -25.54M | -18.91M | -22.09M | -16.44M | -14.41M | -6.78M |
Selling & General & Admin | 32.96M | 26.48M | 24.35M | 18.97M | 15.22M | 10.65M |
Research & Development | 13.9M | 12.39M | 11.71M | 10.89M | 9.28M | 4.69M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 46.86M | 38.87M | 36.06M | 29.86M | 24.5M | 15.34M |
Interest Expense | 2.39M | n/a | n/a | 81K | 973K | 1.44M |
Selling & Marketing Expenses | 16.46M | 14.48M | 12.6M | 9.36M | 7.22M | 5.38M |
Cost & Expenses | 61.14M | 51.14M | 46.4M | 36.88M | 29.67M | 19.05M |
Income Tax Expense | 55K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 28.32M | 27.03M | 24.61M | 24.18M | 20.73M | 15.85M |
Shares Outstanding (Diluted) | 28.32M | 27.03M | 24.61M | 24.18M | 20.73M | 15.85M |
EPS (Basic) | -0.90 | -0.70 | -0.90 | -0.68 | -0.69 | -0.43 |
EPS (Diluted) | -0.90 | -0.70 | -0.90 | -0.68 | -0.69 | -0.43 |
EBITDA | -20.86M | -17.01M | -20.63M | -15.58M | -12.75M | -4.79M |
EBIT | -23.1M | -18.91M | -22.09M | -16.35M | -13.44M | -5.34M |
Depreciation & Amortization | 2.24M | 1.9M | 1.46M | 777K | 692K | 550K |
Add to Watchlist
Select watchlists to add or remove CLPT